MARKET

KHTRF

KHTRF

Knight Therapeut
OTCPK
5.35
+0.03
+0.56%
Opening 10:10 04/01 EDT
OPEN
5.35
PREV CLOSE
5.32
HIGH
5.35
LOW
5.35
VOLUME
100
TURNOVER
535
52 WEEK HIGH
5.35
52 WEEK LOW
4.010
MARKET CAP
524.49M
P/E (TTM)
-135.7868
1D
5D
1M
3M
1Y
5Y
1D
Knight Therapeutics Inc. ranks on The Globe and Mail’s second annual Canada’s Top Growing Women-Led Companies and seventh annual Women Lead Here benchmark of executive gender diversity
Barchart · 5d ago
Analysts Offer Insights on Healthcare Companies: Knight Therapeutics (OtherKHTRF) and Ovid Therapeutics (OVID)
TipRanks · 03/24 12:50
Analysts Offer Insights on Healthcare Companies: Knight Therapeutics (OtherKHTRF) and Chemomab Therapeutics (CMMB)
TipRanks · 03/22 14:20
Knight Therapeutics price target raised to C$8.50 from C$8 at RBC Capital
TipRanks · 03/20 15:50
RBC Capital Remains a Buy on Knight Therapeutics (KHTRF)
TipRanks · 03/20 12:04
Knight Therapeutics reports FY results
Seeking Alpha · 03/19 20:09
Knight Therapeutics Posts Record 2025 Revenue, Sets Confident 2026 Outlook
TipRanks · 03/19 12:21
Knight Therapeutics sees FY26 revenue C$490M-C$510M
TipRanks · 03/19 11:52
More
About KHTRF
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company monitors investments in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by the Company such as Exelon and Impavido.

Webull offers Knight Therapeutics Inc stock information, including OTCPK: KHTRF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KHTRF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KHTRF stock methods without spending real money on the virtual paper trading platform.